glp-1 or semaglutide A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy How Long Does It Take
Description
Tolerability is also a practical concern
A: Semaglutide is intended for individuals with obesity (BMI 30) or overweight individuals (BMI 27) with at least one weight-related health condition
Peptides, on the other hand, produce more gradual and holistic effects over time, supporting overall body composition and long-term metabolic health
[DOI] [PubMed] [Google Scholar] 42.Bataille D., Tatemoto K., Gespach C., Jornvall H., Rosselin G., Mutt V
After removal, bile drains continuously into the duodenum rather than on demand, altering fat absorption and nutrient processing
